What is Cinemark Hldgs Inc's earnings per share (EPS)?

Cinemark Hldgs Inc (CNK) reported diluted earnings per share of $1.04 for fiscal year 2025. This represents a -49.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cinemark Hldgs Inc Financials

CNK

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Cinemark Hldgs Inc (CNK) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CNK FY2025 2026-05-01

Profitability is being driven more by below-the-line swings than by revenue growth in a fixed-charge-heavy business.

Across FY2023-FY2025, revenue stayed near $3.1B, which makes the drop in net margin to 4.4% look less like a demand reset and more like a cost-and-financing issue inside an otherwise steady sales base. That pressure is visible because interest expense nearly matched net income in FY2025, at $142.3M versus $138.2M.

Depreciation and amortization was $201.9M in FY2025, above net income of $138.2M, so this is not an asset-light model and reported earnings sit below a meaningful noncash charge. Without recent cash-flow disclosure, that does not automatically mean abundant free cash, because a theater base can require ongoing reinvestment just to stay productive.

FY2024's profit spike was helped by a -$60.1M tax line, whereas FY2025 carried a $12.4M tax expense, so part of the earnings swing happened below the operating line rather than through a sharp change in sales. That makes the earlier margin peak look less like a new normal and more like a year with unusually favorable profit-bridge items.

Financial Health Signals

Financial Profile 9/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Cinemark Hldgs Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Cinemark Hldgs Inc's revenue grew a modest 2.1% year-over-year to $3.1B. This slow but positive growth earns a score of 35/100.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.1B

YoY+2.1%

5Y CAGR+35.3%

10Y CAGR+0.9%

Cinemark Hldgs Inc generated $3.1B in revenue in fiscal year 2025. This represents an increase of 2.1% from the prior year.

EBITDA

N/A

Net Income

$138.2M

YoY-55.4%

10Y CAGR-4.4%

Cinemark Hldgs Inc reported $138.2M in net income in fiscal year 2025. This represents a decrease of 55.4% from the prior year.

EPS (Diluted)

$1.04

YoY-49.5%

10Y CAGR-5.7%

Cinemark Hldgs Inc earned $1.04 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 49.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

Cinemark Hldgs Inc held $0 in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.33

5Y CAGR-1.7%

10Y CAGR-10.5%

Cinemark Hldgs Inc paid $0.33 per share in dividends in fiscal year 2025.

Shares Outstanding

N/A

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

4.4%

YoY-5.7pp

5Y CAGR+94.3pp

10Y CAGR-3.2pp

Cinemark Hldgs Inc's net profit margin was 4.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 5.7 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

CNK Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$3.1B+2.1%	$3.0B-0.6%	$3.1B+24.9%	$2.5B+62.5%	$1.5B+120.1%	$686.3M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	$161.1M+26.2%	$127.6M
Operating Income	N/A	N/A	N/A	N/A	-$252.5M+66.6%	-$755.0M
Interest Expense	$142.3M-1.2%	$144.0M+195.7%	-$150.4M+3.2%	-$155.3M-3.7%	-$149.7M-215.2%	$129.9M
Income Tax	$12.4M+120.6%	-$60.1M-301.0%	$29.9M+896.7%	$3.0M+117.9%	-$16.8M+94.6%	-$309.4M
Net Income	$138.2M-55.4%	$309.7M+64.6%	$188.2M+169.4%	-$271.2M+35.9%	-$422.8M+31.5%	-$616.8M
EPS (Diluted)	$1.04-49.5%	$2.06+53.7%	$1.34+159.3%	$-2.26+36.3%	$-3.55+32.4%	$-5.25

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$643.1M-17.2%	$776.3M-9.5%	$857.5M-8.8%	$940.5M+73.9%	$540.7M-33.6%	$814.3M-11.7%	$921.8M+25.6%	$734.2M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$34.7M+7.8%	$32.2M0.0%	$32.2M-18.3%	$39.4M+2.3%	$38.5M+10.0%	$35.0M-4.6%	$36.7M+6.1%	$34.6M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$6.4M-118.8%	$34.1M-31.1%	$49.5M-47.1%	$93.5M+340.4%	-$38.9M-175.8%	$51.3M-72.7%	$187.8M+310.0%	$45.8M
EPS (Diluted)	$-0.06	N/A	$0.40-36.5%	$0.63+296.9%	$-0.32	N/A	$1.19+271.9%	$0.32

CNK Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	N/A	N/A	N/A	$4.9B-7.3%	$5.2B-6.0%	$5.6B
Current Assets	N/A	N/A	N/A	$800.9M-8.4%	$874.4M-2.1%	$892.7M
Cash & Equivalents	$0	$0-100.0%	$10.8M-27.5%	$14.9M-97.9%	$707.3M+7.9%	$655.3M
Inventory	N/A	N/A	N/A	$19.6M+26.5%	$15.5M+23.1%	$12.6M
Accounts Receivable	N/A	N/A	N/A	$52.4M-23.8%	$68.8M+172.3%	$25.3M
Goodwill	$1.2B+0.5%	$1.2B-0.9%	$1.3B0.0%	$1.3B+0.2%	$1.2B-0.4%	$1.3B
Total Liabilities	N/A	N/A	N/A	$4.7B-5.1%	$4.9B+2.8%	$4.8B
Current Liabilities	N/A	N/A	N/A	$628.4M-18.3%	$769.1M+26.8%	$606.4M
Long-Term Debt	N/A	N/A	N/A	$2.5B-0.1%	$2.5B+4.2%	$2.4B
Total Equity	N/A	N/A	N/A	$194.8M-39.7%	$322.9M-59.0%	$788.0M
Retained Earnings	N/A	N/A	N/A	-$561.3M-44.1%	-$389.4M-1493.9%	$27.9M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	N/A	$0	N/A	N/A	N/A	$0	$0	N/A
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.2B+0.1%	$1.2B-0.1%	$1.2B+0.1%	$1.2B+0.2%	$1.2B+0.3%	$1.2B-0.5%	$1.2B+0.1%	$1.2B
Total Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Retained Earnings	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CNK Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	N/A	N/A	N/A	N/A	$166.2M+150.4%	-$330.1M
Capital Expenditures	N/A	N/A	N/A	$110.7M+15.9%	$95.5M+13.8%	$83.9M
Free Cash Flow	N/A	N/A	N/A	N/A	$70.7M+117.1%	-$414.0M
Investing Cash Flow	N/A	N/A	N/A	N/A	-$89.3M-7.1%	-$83.4M
Financing Cash Flow	N/A	N/A	N/A	N/A	-$19.9M-103.4%	$584.4M
Dividends Paid	$39.9M	N/A	N/A	N/A	$0-100.0%	$42.3M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

CNK Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	-16.7%+93.3pp	-110.0%
Net Margin	4.4%-5.7pp	10.2%+4.0pp	6.1%+17.2pp	-11.1%+16.9pp	-28.0%+61.9pp	-89.9%
Return on Equity	N/A	N/A	N/A	-139.2%-8.3pp	-130.9%-52.7pp	-78.3%
Return on Assets	N/A	N/A	N/A	-5.6%+2.5pp	-8.1%+3.0pp	-11.1%
Current Ratio	N/A	N/A	N/A	1.27+0.1	1.14-0.3	1.47
Debt-to-Equity	N/A	N/A	N/A	12.70+5.0	7.67+4.7	3.02
FCF Margin	N/A	N/A	N/A	N/A	4.7%+65.0pp	-60.3%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	-1.0%-5.4pp	4.4%-1.4pp	5.8%-4.2pp	9.9%+17.1pp	-7.2%-13.5pp	6.3%-14.1pp	20.4%+14.1pp	6.2%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Atlanta Braves Holdings, Inc BATRA

$3.5B

Manchester Utd Plc MANU

$3.2B

Iqiyi IQ

$1.2B

Atlanta Braves Holdings, Inc BATRK

$3.2B

Sphere Entertainment Co SPHR

$5.2B

Frequently Asked Questions

What is Cinemark Hldgs Inc's annual revenue?

Cinemark Hldgs Inc (CNK) reported $3.1B in total revenue for fiscal year 2025. This represents a 2.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cinemark Hldgs Inc's revenue growing?

Cinemark Hldgs Inc (CNK) revenue grew by 2.1% year-over-year, from $3.0B to $3.1B in fiscal year 2025.

Is Cinemark Hldgs Inc profitable?

Yes, Cinemark Hldgs Inc (CNK) reported a net income of $138.2M in fiscal year 2025, with a net profit margin of 4.4%.

What is Cinemark Hldgs Inc's net profit margin?

Cinemark Hldgs Inc (CNK) had a net profit margin of 4.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Cinemark Hldgs Inc pay dividends?

Yes, Cinemark Hldgs Inc (CNK) paid $0.33 per share in dividends during fiscal year 2025.

How financially healthy is Cinemark Hldgs Inc?

Cinemark Hldgs Inc (CNK) scores 9 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.